Charming Medical Ltd filed a Form F-1 registration statement for an initial public offering on 2025-05-14. It has amended it 3 times. It filed its final prospectus on 2025-10-21. Each fact below is quoted from the filing named with it.
What the filings say
Listing
Our Class A Ordinary Shares have been approved for listing on the Nasdaq Capital Market (the “ Nasdaq ”) under the symbol “MCTA.”From the 424B4 filed 2025-10-21
Shares offered
We are offering 1,600,000 Class A Ordinary Shares, representing 10.71% of the issued and outstanding Class A Ordinary Shares issued and outstanding following completion of the Offering, assuming the underwriters do not exercise the over-allotment option, or 1,840,000 Class A Ordinary Shares, representing 12.12% of the issued and outstanding Class A Ordinary Shares following completion of the Offering, assuming the underwriters exercise their over-allotment option in full.From the 424B4 filed 2025-10-21
Revenue
We generated revenue of $6,221,751 and $6,015,375, respectively, and achieved a net income of $1,199,085 and $821,743, respectively, for the years ended March 31, 2025 and 2024.From the F-1/A filed 2025-07-30
Net loss or income
We generated revenue of $6,221,751 and $6,015,375, respectively, and achieved a net income of $1,199,085 and $821,743, respectively, for the years ended March 31, 2025 and 2024.From the F-1/A filed 2025-07-30
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2025-05-14 | Registration statement filed (foreign issuer) | F-1 |
| 2025-05-27 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-07-30 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-09-10 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-10-21 | Final prospectus filed: the offering is priced | 424B4 |
Tools for this story
Each opens in a new tab, filled in for Charming Medical Ltd. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.